DK1059921T3 - Anvendelse af macrolidforbindelser til behandling af ARDS - Google Patents

Anvendelse af macrolidforbindelser til behandling af ARDS

Info

Publication number: DK1059921T3
Authority: DK; Denmark
Prior art keywords: treatment; ards; macrolide compounds; compounds; macrolide
Prior art date: 1998-03-06

Application number

DK99937870T

Other languages

English (en)

Inventor

Tadatsura Koshika

Itsuo Nagatomi

Original Assignee

Fujisawa Pharmaceutical Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-03-06

Filing date

1999-03-04

Publication date

2003-10-27

1999-03-04 Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co

2003-10-27 Application granted granted Critical

2003-10-27 Publication of DK1059921T3 publication Critical patent/DK1059921T3/da

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Molecular Biology (AREA)
Pain & Pain Management (AREA)
Pulmonology (AREA)
Rheumatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Saccharide Compounds (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Silicates, Zeolites, And Molecular Sieves (AREA)
Steroid Compounds (AREA)
Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

DK99937870T 1998-03-06 1999-03-04 Anvendelse af macrolidforbindelser til behandling af ARDS DK1059921T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
AUPP2231A AUPP223198A0 (en)	1998-03-06	1998-03-06	New use
PCT/JP1999/001064 WO1999044597A2 (en)	1998-03-06	1999-03-04	Use of macrolide compounds for the treatment of ards

Publications (1)

Publication Number	Publication Date
DK1059921T3 true DK1059921T3 (da)	2003-10-27

Family

ID=3806495

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK99937870T DK1059921T3 (da)	1998-03-06	1999-03-04	Anvendelse af macrolidforbindelser til behandling af ARDS

Country Status (15)

Country	Link
US (1)	US6333334B1 (da)
EP (1)	EP1059921B1 (da)
JP (1)	JP3367105B2 (da)
KR (1)	KR100395571B1 (da)
CN (1)	CN1133429C (da)
AT (1)	ATE244008T1 (da)
AU (1)	AUPP223198A0 (da)
BR (1)	BR9908796A (da)
CA (1)	CA2322027C (da)
DE (1)	DE69909257T2 (da)
DK (1)	DK1059921T3 (da)
ES (1)	ES2196840T3 (da)
HK (1)	HK1036406A1 (da)
PT (1)	PT1059921E (da)
WO (1)	WO1999044597A2 (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20070032853A1 (en)	2002-03-27	2007-02-08	Hossainy Syed F	40-O-(2-hydroxy)ethyl-rapamycin coated stent
US20050118344A1 (en)	2003-12-01	2005-06-02	Pacetti Stephen D.	Temperature controlled crimping
RU2470623C2 (ru) *	2006-09-29	2012-12-27	Инфа С.А.	Упаковка с фармацевтической композицией и комплект для внутривенного введения
WO2008083160A2 (en) *	2006-12-28	2008-07-10	Limerick Biopharma, Inc.	Methods and compositions for therapeutic treatment
WO2008127746A1 (en)	2007-01-10	2008-10-23	Board Of Regents The University Of Texas System	Enhanced delivery of immunosuppressive drug compositions for pulmonary delivery
CN101011414B (zh) *	2007-01-29	2010-07-21	褚福明	一种肺脑合剂药物
AU2008282261A1 (en) *	2007-07-31	2009-02-05	Limerick Biopharma, Inc.	Phosphorylated pyrone analogs and methods
CN101810633B (zh) *	2010-03-31	2011-12-14	湖北丝宝药业有限公司	地红霉素在制备治疗慢性非感染性呼吸道疾病药物的用途
GB201212773D0 (en) *	2012-07-18	2012-08-29	Ucl Business Plc	Vascular remodelling

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4894366A (en) *	1984-12-03	1990-01-16	Fujisawa Pharmaceutical Company, Ltd.	Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same
GB2248184A (en) *	1990-09-28	1992-04-01	Fujisawa Pharmaceutical Co	New use of macrolide compounds for active oxygen-mediated diseases
CA2054983A1 (en) *	1990-11-08	1992-05-09	Sotoo Asakura	Suspendible composition and process for preparing the same
WO1992008474A2 (en) *	1990-11-20	1992-05-29	The National Heart & Lung Institute	Treatment of lung diseases
US5208241A (en) *	1991-09-09	1993-05-04	Merck & Co., Inc.	N-heteroaryl, n-alkylheteroaryl, n-alkenylheteroaryl and n-alkynylheteroarylmacrolides having immunosuppressive activity
GB9218027D0 (en) *	1992-08-25	1992-10-14	Fisons Plc	Novel method of treatment
US5290689A (en) *	1992-09-28	1994-03-01	Merck & Co., Inc.	New cyclic FR-900520 microbial biotransformation agent

1998
- 1998-03-06 AU AUPP2231A patent/AUPP223198A0/en not_active Abandoned
1999
- 1999-03-04 AT AT99937870T patent/ATE244008T1/de not_active IP Right Cessation
- 1999-03-04 US US09/623,595 patent/US6333334B1/en not_active Expired - Fee Related
- 1999-03-04 KR KR10-2000-7009080A patent/KR100395571B1/ko not_active IP Right Cessation
- 1999-03-04 DE DE69909257T patent/DE69909257T2/de not_active Expired - Lifetime
- 1999-03-04 EP EP99937870A patent/EP1059921B1/en not_active Expired - Lifetime
- 1999-03-04 DK DK99937870T patent/DK1059921T3/da active
- 1999-03-04 WO PCT/JP1999/001064 patent/WO1999044597A2/en active IP Right Grant
- 1999-03-04 ES ES99937870T patent/ES2196840T3/es not_active Expired - Lifetime
- 1999-03-04 CN CNB998036676A patent/CN1133429C/zh not_active Expired - Fee Related
- 1999-03-04 CA CA002322027A patent/CA2322027C/en not_active Expired - Fee Related
- 1999-03-04 BR BR9908796-0A patent/BR9908796A/pt not_active Application Discontinuation
- 1999-03-04 JP JP54454999A patent/JP3367105B2/ja not_active Expired - Fee Related
- 1999-03-04 PT PT99937870T patent/PT1059921E/pt unknown
2001
- 2001-10-17 HK HK01107256A patent/HK1036406A1/xx not_active IP Right Cessation

Also Published As

Publication number	Publication date
BR9908796A (pt)	2000-10-31
EP1059921B1 (en)	2003-07-02
AUPP223198A0 (en)	1998-04-02
DE69909257D1 (de)	2003-08-07
WO1999044597A3 (en)	1999-12-29
CN1133429C (zh)	2004-01-07
EP1059921A2 (en)	2000-12-20
CA2322027C (en)	2009-05-12
WO1999044597A2 (en)	1999-09-10
DE69909257T2 (de)	2004-02-19
HK1036406A1 (en)	2002-01-04
KR100395571B1 (ko)	2003-08-21
ATE244008T1 (de)	2003-07-15
CN1292695A (zh)	2001-04-25
CA2322027A1 (en)	1999-09-10
KR20010041046A (ko)	2001-05-15
PT1059921E (pt)	2003-11-28
US6333334B1 (en)	2001-12-25
JP2001520682A (ja)	2001-10-30
ES2196840T3 (es)	2003-12-16
JP3367105B2 (ja)	2003-01-14

Publication	Publication Date	Title
DK1056454T3 (da)	2003-08-18	Anvendelse af makrolidforbindelser til behandling af glaukom
EA200601554A1 (ru)	2006-12-29	Замещенные индол-о-глюкозиды
NO20006630L (no)	2001-02-26	Farmasöytisk sammensetning for behandlingen av diabetes
TR200001203T2 (tr)	2000-08-21	Yeni birleşik maddeler
TR200101412T2 (tr)	2001-10-22	Yeni bileşikler.
EA200601552A1 (ru)	2007-02-27	Замещенные конденсированные гетероциклические с-гликозиды
DK2412368T3 (da)	2013-11-04	Sammensætning til behandling af ar
TR200201057T2 (tr)	2002-09-23	P38 protein kinazı inhibitörleri olarak heteroalkilamino ikameli bisiklik nitrojen heterosaykılları.
PT1169370E (pt)	2006-07-31	Solucoes de poliuretano contendo unidades estruturais de alcoxissilano.
AP1424A (en)	2005-06-06	2-Phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole in combination with estrogens.
PT842934E (pt)	2004-03-31	Agonistas de 5-ht1f
EE200200208A (et)	2003-06-16	Oligosahhariidid, nende valmistamismeetod ja kasutamine ning farmatseutilised kompositsioonid
NZ507350A (en)	2003-03-28	Semi-synthetic ecteinascidins and use in treatment of tumors
NO20005793D0 (no)	2000-11-16	Sammensetninger som inneholder organisk mono- eller dinitrat for behandling av impotens
WO2001035950A3 (en)	2001-11-29	Benzamide therapeutics and methods for treating inflammatory bowel disease
ES2243579T3 (es)	2005-12-01	Derivados de pirazolopirideno.
ID26055A (id)	2000-11-23	Senyawa-senyawa hidroksidifenil eter
ATE180781T1 (de)	1999-06-15	Kristallines tiagabinehydrochlorid-monohydrat, seine herstellung und verwendung
DK1059921T3 (da)	2003-10-27	Anvendelse af macrolidforbindelser til behandling af ARDS
SE9604348D0 (sv)	1996-11-26	Användning av hydroxyguanidiner
TR199903132A3 (tr)	2000-07-21	Metalosan bilesiklerinin aktive edici kompozisyonu.
DE60116106D1 (de)	2006-01-26	Benzofuran derivate und ihre verwendung als antibakterielle wirkstoffe
DE60202590D1 (de)	2005-02-17	2h-1-benzopyran-derivate, prozesse zu ihrer herstellung und pharmazeutische zusammensetzungen
SE9904128D0 (sv)	1999-11-15	Novel compounds
DK1607090T3 (da)	2012-01-30	Asimadolin til behandling af irritabel tyktarm (Irritable Bowel Syndrome)